Home >  News >  Industry >  Pharma News >  Inter-state illegal...

Inter-state illegal pharma supply, manufacturing network busted by Punjab Police

By - Ruchika Sharma
Published On 2024-05-13 11:45 GMT   |   Update On 2024-05-13 11:45 GMT
Advertisement

Amritsar: Punjab Police busted an inter-state network involved in the illegal supply and manufacturing of pharmaceuticals, operating out of a pharma factory in Himachal Pradesh, a senior official stated on Saturday

"In a major intelligence-based operation against Pharma Opioids, Special Task Force (STF) of Punjab Police has busted an interstate network of manufacturing illegal psychotropic substances and supply units running from a pharma factory based in Baddi of Himachal Pradesh, said Director General of Police (DGP) Gaurav Yadav here on Saturday," as per a Punjab Information And Public Relations Department press release.

Advertisement
The development came after the three-month-long meticulous investigations of backward and forward linkages carried out by the Special Task Force, Border Range, Amritsar into the arrest of two drug smugglers identified as Sukhwinder Singh alias Dhami of village Kot Muhammad Khan in Tarn Taran and Jaspreet Singh alias Jass of Govind Nagar in Amritsar, who were arrested after the recovery of 4.24 lakh narcotic tablets/capsules and Rs 1 lakh drug money from Beas in February this year.
"During this entire operation spread across five states, the Police have arrested a total of seven drug smugglers/suppliers and made an effective recovery of 70.42 lakh Intoxicant Tablets/Capsules, 725.5 kg Intoxicant Tramadol Powder and Rs 2.37 lakh drug money. Five states include Punjab, Haryana, Himachal Pradesh, Uttar Pradesh and Maharashtra," as per the release.
Accoding to ANI report, DGP Gaurav Yadav said that following the trail after the arrest of these two drug smugglers, Police teams led by SP STF Vishaljit Singh and DSP STF Vavinder Kumar have managed to trace and arrest the main kingpin of the racket identified as Alex Paliwal from Saharanpur in Uttar Pradesh after recovering 9.04 lakh Intoxicant Tablets/capsules and Rs 1.37 lakh drug money from his possession.
"He said that following the revelations of accused Alex Paliwal, the operation was then extended to Himachal Pradesh, where Police teams in the presence of Drug Control Officers Sukhdeep Singh and Ramneek Singh have scrutinised Biogenetic Drug Private Limited and seized records showing that the company has manufactured over 20 crore Alprazolam tablets in just eight months," the release stated.
The records have also traced the supply chain to M/s Aster Pharma in Maharashtra, where further investigative measures led to the exposing Biogenetic Drug Private Limited's sister pharma manufacturing company Smilex Pharmachem Drug Industries based in Baddi, he added.
"The DGP said that the subsequent operation targeting Smilex Pharmachem Drug Industries yielded a substantial seizure of 47.32 lahks intoxicant capsules and 725.5 kg of Intoxicant Tramadol Powder-- sufficient to manufacture 1.5 crore capsules. The records revealed that Smilex Pharmachem Drug Industries purchased 6500 Kg of intoxicant tramadol powder within a year," as per the release.
He said that the concurrent investigations into transportation and distribution led to the apprehension of individuals including Intezar Salmani, Prince Salmani, Baljinder Singh, and Suba Singh unravelling the intricate web of interstate drug trafficking. Police teams have recovered another chunk of 9.80 lakh intoxicant tablets/capsules from a transportation vehicle near the Chandigarh Railway Station. Further investigations are on and more arrests are expected, he said.
A case had been registered under sections 22-C, 25, 27-A, and 29 of the NDPS Act at Police Station STF, SAS Nagar.
Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

USFDA approves expanded indication for Takeda Vonvendi for adults, children with Von Willebrand Disease

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

SC Questions Effectiveness of UCPMP, Seeks Govt Clarification on Pharma Freebies

Dr Reddy's Labs API Mirfield facility gets 7 USFDA observations

CDSCO Panel Rejects Theon Pharma's Proposal for Empagliflozin, Linagliptin, Metformin FDC

Virchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III Trials

Industry needs to come forward, take advantage of funds available for MedTech Sector: DoP Joint Secretary

USFDA inspection: Aurobindo Pharma receives 8 observations for Unit-XII